サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606509

人工股関節と人工膝関節の世界市場-2024～2031年

Global Hips & Knees Reconstructive Market - 2024-2031

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
人工股関節と人工膝関節の世界市場-2024～2031年
出版日: 2024年12月04日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

人工股関節と人工膝関節の世界市場は、2023年に173億米ドルに達し、2031年には229億3,000万米ドルに達すると予測され、予測期間2024年にはCAGR 3.6%で成長する見込みです。

股関節と膝関節の再建術は、変形性関節症、関節リウマチ、事故、その他の退行性疾患などの障害によって影響を受けた股関節と膝関節の機能と完全性を回復するために考案された外科的介入です。これらの治療は通常、損傷した関節部品を、健康な関節の自然な可動性と機能を模倣した人工インプラントで置き換えることを伴います。股関節と膝関節の再建術には、人工関節全置換術と人工関節部分置換術の2種類があります。人工関節全置換術では、損傷した関節面をすべて取り除き、人工関節と呼ばれる人工部品に置き換えます。これらの人工関節は、健康な関節の形や動きを模倣して精密に作られています。

高齢者の増加が、予測期間中の市場を牽引する要因です。例えば、汎米保健機構（Pan American Health Organization）によると、世界全体では、2,000万人の新規がん診断と1,000万人のがん死亡が予想されています。今後20年間で、がんの負担は60％近く増加し、医療システム、個人、地域社会にさらなる負担を強いることになります。例えば、国連によれば、世界の65歳以上の高齢者数は2倍以上に増加し、2021年の7億6,100万人から2050年には16億人になると予測されています。80歳以上の高齢者数はさらに急速に増加します。人口の高齢化は不可逆的な世界の動向です。

市場力学：

促進要因と抑制要因

高齢者の増加

高齢者の増加は、世界の人工股関節と人工膝関節市場の成長において重要な要因となることが予想されます。人口の高齢化に伴い、変形性関節症や関節リウマチといった加齢に伴う関節疾患の有病率が増加します。これらの病気は、かなりの痛み、可動域制限、生活の質の低下を頻繁に引き起こし、多くの高齢者を股関節置換術や膝関節置換術などの外科的治療に駆り立てる。調査によると、問題のリスクが高いにもかかわらず、高齢の患者は、痛みの軽減や機能性の向上という点で、これらの治療がもたらす大きな利点のために、人工股関節置換術や人工膝関節置換術を受ける傾向が強くなっています。さらに、手術手技やインプラント技術の向上により、これらの手術は高齢者にとってもより安全で成功しやすくなっています。

例えば、WHOによると、2050年には高齢者の80％が低・中所得国に住むようになるといいます。人口の高齢化のペースは、過去に比べてはるかに速くなっています。2020年には、60歳以上の人口が5歳以下の子どもを上回ります。2015～2050年にかけて、世界の人口に占める60歳以上の割合は12％から22％へとほぼ倍増します。2030年には、世界の6人に1人が60歳以上となります。この時、60歳以上の人口に占める割合は2020年の10億人から14億人に増加します。2050年には、世界の60歳以上の人口は2倍（21億人）になります。80歳以上の高齢者の数は、2020～2050年の間に3倍となり、4億2,600万人に達すると予想されています。

インプラントや手術の高額な費用

インプラントや手術にかかる費用の高さといった要因が、世界の人工股関節と人工膝関節市場を阻害すると予想されます。インプラントや外科的処置のコストが高いことは、産業の成長を妨げる大きな要因です。こうした経済的な制約は、特に低所得の患者や医療保険が完全に適用されない患者にとって、重要な治療法へのアクセスを妨げる可能性があります。人工股関節全置換術（THA）や人工膝関節全置換術（TKA）の手術費用は高額で、術前検査、手術、術後のリハビリテーションをすべて合わせると、数千ドルかかることも多いです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 高齢化人口の増加
    • 抑制要因
      • インプラントと手術の高額な費用
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • 特許分析
  • SWOT分析
  • DMIの見解

第6章 膝関節置換術別

  • トータルニーシステム
  • 部分膝関節システム
  • 膝関節再置換システム

第7章 股関節置換術別

  • トータルヒップシステム
  • 部分股関節システム
  • 股関節再置換システム

第8章 固定方法別

  • セメント固定
  • セメントレス固定
  • ハイブリッド固定

第9章 エンドユーザー別

  • 病院・クリニック
  • 外来手術センター
  • 整形外科クリニック
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Zimmer Biomet
  • DePuy Synthes
  • Smith & Nephew plc.
  • Stryker
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Exactech Inc.
  • Limacorporate S.p.a.
  • CeramTec
  • ConforMIS

第13章 付録

目次
Product Code: MD8801

Overview

The global hips & knees reconstructive market reached US$ 17.30 billion in 2023 and is expected to reach US$ 22.93 billion by 2031, growing at a CAGR of 3.6% during the forecast period 2024-2031.

Hip and knee reconstructive procedures are surgical interventions designed to restore the function and integrity of hip and knee joints that have been affected by disorders such as osteoarthritis, rheumatoid arthritis, accident, or other degenerative diseases. These treatments usually entail replacing damaged joint components with artificial implants that mimic the natural mobility and function of healthy joints. The two main types of hip and knee reconstructive procedures are total joint replacement and partial joint replacement. Total joint replacement involves removing all damaged joint surfaces and replacing them with artificial components known as prostheses. These prostheses are precisely constructed to mimic the shape and movement of healthy joints.

The increasing prevalence of geriatric population is the driving factor that drives the market over the forecast period. For instance, according to the Pan American Health Organization, globally, there were an expected 20 million new cancer diagnoses and 10 million cancer deaths. Over the next two decades, the cancer burden will rise by almost 60%, putting a further burden on healthcare systems, individuals, and communities. For instance, according to the United Nations, The number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050. The number of people aged 80 years or older is growing even faster. Population ageing is an irreversible global trend.

Market Dynamics: Drivers & Restraints

Increasing geriatric population

The increasing geriatric population is expected to be a significant factor in the growth of the global hips & knees reconstructive market. As the population ages, the prevalence of age-related joint diseases such osteoarthritis and rheumatoid arthritis increases. These diseases frequently cause considerable pain, restricted mobility, and a lower quality of life, driving many senior people to seek surgical treatments such as hip and knee replacements. According to research, despite being at a higher risk of problems, older patients are becoming more inclined to undergo hip and knee replacements due to the significant benefits these treatments provide in terms of pain reduction and enhanced functionality. Furthermore, improvements in surgical techniques and implant technology have made these surgeries safer and more successful for older people.

For instance, according to WHO, in 2050, 80% of older people will be living in low- and middle-income countries. The pace of population aging is much faster than in the past. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

High Costs of Implants and Procedures

Factors such as high costs of implants and procedures are expected to hamper the global hips & knees reconstructive market. The high cost of implants and surgical procedures is a major hindrance to industry growth. These financial constraints can impede access to important therapies, especially for low-income patients or those without complete health insurance coverage. Total hip arthroplasty (THA) and total knee arthroplasty (TKA) operations can be expensive, frequently costing several thousand dollars when pre-operative examinations, surgery, and post-operative rehabilitation are all added together.

Segment Analysis

The global hips & knees reconstructive market is segmented based on knee replacement, hip replacement, fixation method, end-user, and region.

Knee replacement segment is expected to dominate the global hips & knees reconstructive market share

The knee replacement segment is expected to dominate the global hips and knees reconstructive market, owing to the rising prevalence of knee-related disorders and the increasing desire for effective surgical solutions. As osteoarthritis and other degenerative joint illnesses become more frequent, particularly among the elderly, the demand for knee replacements is increasing rapidly. This tendency is bolstered by the acceptance of knee replacement procedures as realistic solutions for regaining mobility and improving quality of life.

Advances in medical technology have also contributed significantly to the expansion of the knee replacement market. Innovations such as minimally invasive surgical techniques and improved implant designs have made operations safer and more effective, resulting in improved patient outcomes. These innovations not only extend the life of implants, but also appeal to a broader spectrum of patients, including younger people who are increasingly seeking knee replacements due to their active lives.

For instance, in June 2024, Meril, a Gujarat-based medical devices company, has launched an indigenously developed surgical robotic technology, MISSO, which will provide assistance to doctors during knee replacement surgeries in real-time. It is expected to make these surgeries up to 66 per cent budget friendly.

Geographical Analysis

North America is expected to hold a significant position in the global hips & knees reconstructive market share

North America is expected to hold a significant portion of the global hips & knees reconstructive market. North America is likely to maintain its dominant position in the worldwide hips and knees reconstructive market, owing to a mix of demographic trends, technological improvements, and a strong healthcare infrastructure. The region's aging population is one of the key drivers of the rising need for joint reconstruction surgeries. As people age, they become more prone to musculoskeletal problems like arthritis, which frequently demand surgical interventions such as hip and knee replacements. This demographic transition not only increases the need for these procedures, but also emphasizes the importance of appropriate healthcare solutions suited to elderly people.

For instance, according to urban.org, the number of Americans aged 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The number of adults ages 85 and older, the group most often needing help with basic personal care, will nearly quadruple between 2000 and 2040. For an instance, according to America Health Ranking.org, 17.3% of the entire US population is geriatric population.

Asia Pacific is growing at the fastest pace in the global hips & knees reconstructive market

Asia Pacific is experiencing the fastest growth in global hips & knees reconstructive owing to the increasing incidence of chronic diseases and technological advancements in the region. The Asia Pacific region is experiencing the fastest growth in the global hips and knees reconstructive market, owing to a combination of demographic shifts, increased healthcare investments, and growing awareness of joint health. The aging population in many of the region's countries is one of the most significant contributors to its rapid growth. As life expectancy rises and birth rates fall, a bigger proportion of the population enters the elderly age bracket, which coincides with a higher prevalence of joint-related diseases like osteoarthritis.

The increasing geriatric population is one of the driving factors in this region making it the fastest growing region. For instance, according to the UNFPA India, he current elderly population of 153 million (aged 60 and above) is expected to reach a staggering 347 million by 2050.

Competitive Landscape

The major global players in the global hips & knees reconstructive market include F. Hoffmann-La Roche Ltd, Abbott, Hologic, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Revvity, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Illumina, Inc., and Sysmex Corporation among others.

Emerging Players

Genomtec, QuantiLight, and GeneSys Bio among others

Key Developments

  • In April 2024, Kharadi's Manipal Hospital launched robotic knee replacement surgery, promising better accuracy and quicker recovery. Manipal Hospital, Kharadi has unveiled advanced robotic knee replacement surgery, promising improved precision, faster recovery times, and reduced pain compared to traditional procedures.
  • In October 2024, Smith+Nephew announced that it launched its Legion hinged knee (HK) system with Oxinium implant technology in the U.S. Oxinium implant technology helps to mitigate the common risk factors associated with revision procedures. Legion revision with Oxinium delivers high-performing bearing with low risks of re-revision compared to the class average.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global hips & knees reconstructive market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Knee Replacement
  • 3.2. Snippet by Hip Replacement
  • 3.3. Snippet by Fixation Method
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Geriatric Population
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs of Implants and Procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Knee Replacement

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
    • 6.1.2. Market Attractiveness Index, By Knee Replacement
  • 6.2. Total Knee Systems*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Partial Knee System
  • 6.4. Revision Knee Systems

7. By Hip Replacement

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
    • 7.1.2. Market Attractiveness Index, By Hip Replacement
  • 7.2. Total Hip Systems *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Partial Hip Systems
  • 7.4. Revision Hip Systems

8. By Fixation Method

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
    • 8.1.2. Market Attractiveness Index, By Fixation Method
  • 8.2. Cemented Fixation*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cementless Fixation
  • 8.4. Hybrid Fixation

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Orthopedic Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. The U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. UK
      • 10.3.8.3. France
      • 10.3.8.4. Italy
      • 10.3.8.5. Spain
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Zimmer Biomet*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. DePuy Synthes
  • 12.3. Smith & Nephew plc.
  • 12.4. Stryker
  • 12.5. MicroPort Scientific Corporation
  • 12.6. B. Braun Melsungen AG
  • 12.7. Exactech Inc.
  • 12.8. Limacorporate S.p.a.
  • 12.9. CeramTec
  • 12.10. ConforMIS

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us